News

Mass Eye and Ear scientists attend ARO Mid-Winter Meeting

February 22, 2023

A cohort of investigators from the Department of OHNS travelled to Orlando, FL, for the 46th annual Mid-Winter Meeting of the Association for Research in Otolaryngology (ARO).

ARO is the largest organization of hearing, speech and balance researchers in the world. Principle investigators, trainees and staff from the department—as well as students from the Speech and Hearing & Biosciences and Technology Graduate Program—attended the four-day meeting. Collectively, they delivered eight podium and more than 50...

Read more about Mass Eye and Ear scientists attend ARO Mid-Winter Meeting

Mass Eye and Ear Celebrates Inaugural OHNS Faculty Recognition Gala

December 9, 2022

Harvard Medical School faculty from the Department of Otolaryngology–Head and Neck Surgery (OHNS) at Mass Eye and Ear gathered at the Harvard Club on the evening of Friday, December 9, in celebration of Mass Eye and Ear’s inaugural OHNS Faculty Recognition Gala.

The inaugural gala was launched by the Otolaryngology–Head and Neck Surgery Education Office at Mass Eye and Ear in collaboration with senior members of the hospital’s departmental Leadership Team. Several awards were bestowed to faculty members, each of whom exemplified a unique, longstanding standard of excellence...

Read more about Mass Eye and Ear Celebrates Inaugural OHNS Faculty Recognition Gala

Dr. Zheng-Yi Chen Named Co-PI of $4 million NIH Grant for Gene-Editing Solutions to Usher Syndrome

August 30, 2022

Zheng-Yi Chen, DPhil, Associate Professor of Otolaryngology–Head and Neck Surgery at Harvard Medical School and Associate Scientist in the Eaton-Peabody Laboratories at Mass Eye and Ear, has been named a Principal Investigator (PI) of a $4 million, multi-PI R01 grant from the National Institutes of Health (NIH), which will fund the development of gene-editing treatments for different forms of Usher syndrome, a rare hereditary condition responsible for...

Read more about Dr. Zheng-Yi Chen Named Co-PI of $4 million NIH Grant for Gene-Editing Solutions to Usher Syndrome